Y0000852

Estradiolbenzoat für die Systemeignung

European Pharmacopoeia (EP) Reference Standard

• Synonym(e): β-Oestradiol-3-benzoat, 1,3,5(10)-Estratrien-3,17β-diol-3-benzoat, 3,17β-Dihydroxy-1,3,5(10)-estratrien-3-benzoat, 3-Benzoyloxy-17β-oestrol
• Empirische Formel (Hill-System): C₂₅H₂₈O₃
• CAS-Nummer: 50-50-0
• Molekulargewicht: 376.49
• Beilstein: 3107526
• MDL-Nummer: MFCD00003692
• UNSPSC-Code: 41116107
• PubChem Substanz-ID: 329831190
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: estradiol
• Hersteller/Markenname: EDQM
• mp (Schmelzpunkt): 191-198 °C (lit.)
• Anwendung(en): pharmaceutical (small molecule)
• Format: neat
• Lagertemp.: 2-8°C
• SMILES String: [H][C@]12CC[C@]3(C)[C@@H](O)CC[C@@]3([H])[C@]1([H])CCc4cc(OC(=O)c5ccccc5)ccc24
• InChI: 1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1
• InChIKey: UYIFTLBWAOGQBI-BZDYCCQFSA-N

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Verwendet in Studien zum allgemeinen Steroidmetabolismus und Basisabklärungen für anaboles Steroid-Screening bei Sportlern

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS08
• Signalwort: Danger
• H-Sätze: H351,H360FD
• P-Sätze: P201 - P202 - P280 - P308 + P313 - P405 - P501
• Gefahreneinstufungen: Carc. 2 - Repr. 1B
• Lagerklassenschlüssel: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3